Albemarle (ALB)
(Delayed Data from NYSE)
$100.63 USD
-2.88 (-2.78%)
Updated Jun 17, 2024 04:00 PM ET
After-Market: $100.79 +0.16 (0.16%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Albemarle Corporation [ALB]
Reports for Purchase
Showing records 181 - 200 ( 773 total )
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
4Q21 Follow-Up - Price Execution Offset by Higher Costs
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Company: Albemarle Corporation
Industry: Chemical - Diversified
4Q21 First Look - Strong Lithium Pricing Partially Offset by Cost Increases
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Comprehensive Technical and Fundamental Analysis for ALB.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Comprehensive Technical and Fundamental Analysis for ALB.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Comprehensive Technical and Fundamental Analysis for ALB.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Company: Albemarle Corporation
Industry: Chemical - Diversified
4Q21 Earnings Preview - We Prefer Value in Specialties Over Commodities
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Company: Albemarle Corporation
Industry: Chemical - Diversified
Company: Albemarle Corporation
Industry: Chemical - Diversified
3Q21 Follow-Up - We Bump Target on Good Execution in Li, Bromine Upside
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
3Q21 First Look - 3Q Beat in All Segments; 4Q Guide in Line with Consensus
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department